pelvic floor innervation, and chronic straining may increase prolapse risk. Our objective is to assess and present our experience with the management and outcomes of prolapse in these women.
INTRODUCTION AND OBJECTIVES:
The majority of spina bifida (SB) patients are now living to adulthood, however finding adult providers to care for these patients is a known transitional challenge. We evaluated the use of the emergency room (ER) by these patients, the presenting complaint, rates of admission, and diagnosis.
METHODS: A retrospective review of all patients with a diagnosis of spina bifida and neurogenic bladder presenting to the Northwestern University Hospital ER from 2008-2015 was conducted. Information on chief complaint, admission disposition, imaging utilization and admission diagnosis were collected.
RESULTS: 231 patients were identified that met study criteria. The chief complaint was abdominal pain/nausea/vomiting/diarrhea in 33 (14.3%), headache/shunt issues in 30 (13.0%), skin issues or pressure sores in 25 (10.8%), chills/fevers of unknown origin in 22 (9.5%), urinary tract infection (upper or lower) in 22 (9.5%), back/flank pain in 16 (5 with known nephrolithiasis), catheter issues in 13 (5.6%), chest pain/cough in 12 (5.2%), post-operative complications in 8 (3.5%), and dialysis complications in 7 (3.0%), with the remainder comprising a variety of complaints. Of 231 SB patients, 199 (90%) were kept overnight, 179 (77%) for inpatient hospitalization and 13% for overnight observation. The most common admitting diagnoses were urinary tract infection, abdominal pain, cellulitis, and osteomyelitis. Of these 231 patients, 154 (68%) had a urine culture sent regardless of chief complaint.
CONCLUSIONS: Adult SB patients present to the emergency with varied chief complaints. The overwhelming majority are admitted for inpatient management. The most common chief complaints were abdominal pain, headache/shunt issues, and skin issues/pressure sores. The majority of patients had a urine culture sent despite frequent non-urologic chief complaints.
Source of Funding:
Supported by the National Institutes of Health's National Center for Advancing Translational Sciences, Grant Number UL1TR001422.
PD39-12 UNDERSTANDING CAREGIVERS AND CAREGIVER BURDEN AMONG THOSE CARING FOR PATIENTS WITH CONGENITAL UROLOGIC CONDITIONS
Michael Sadighian*, Elaine Allen, San Francisco, CA; Nima Baradaran, Columbus, OH; Kathryn Quanstrom, Benjamin Breyer, Hillary Copp, Lindsay Hampson, San Francisco, CA INTRODUCTION AND OBJECTIVES: Little is known about caregivers of patients with congenital urologic conditions and the burden they experience. The primary aims of this study are to: 1) identify baseline characteristics of these caregivers and the patients they care for, and 2) identify predictors of caregiver burden in this population.
METHODS: An anonymous survey was distributed via Facebook advertising to caregivers of patients with congenital urologic conditions. Caregiver burden was scored using the Caregiver Burden Inventory (CBI), where CBI !36 indicates risk of burnout. Patient urinary symptoms were assessed utilizing the Neurogenic Bladder Symptom Score (NBSS). The Transitional Readiness Assessment Questionnaire (TRAQ) was used to assess caregiver independence. STATA 15.1 was utilized for statistical analyses with a p<0.05 considered statistically significant.
RESULTS: In our study population (n[453), 26% of caregivers are so burdened by the care they provide that they are at risk of burning out (CBI score !36). Caregivers tended to be female (96.0%), married (79.1%), and had been serving as caregiver for 9 years on average. Bivariate analysis showed that CBI scores !36 were significantly associated with caregiver gender, household income, number of tasks performed by the caregiver, and NBSS. Models predicting overall caregiver burden showed less burden among older patients and those with higher income. Higher caregiver burden was associated with female caregivers.
CONCLUSIONS: Caregivers of patients with congenital urologic conditions experience significant burden. Based on our findings, urologists may be able to lessen caregiver burden by addressing urinary symptoms. Overall, helping patients become more independent so they are less reliant on their caregivers to help them perform caregiving tasks may also improve caregiver strain.
INTRODUCTION AND OBJECTIVES:
We provide updated comparative effectiveness based on long-term, 18-year prostate cancer-specific mortality (PCSM) among men who underwent radical prostatectomy (RP), men who received brachytherapy (BT), externalbeam radiation therapy (EBRT), primary androgen deprivation therapy (PADT) or monitoring (AS/WW) for localized prostate cancer.
METHODS: Within the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) registry, we analyzed 9,774 men with localized prostate cancer. Prostate cancer risk was assessed using the Kattan preoperative nomogram and the Cancer of the Prostate Risk Assessment (CAPRA) score. A multivariable analysis was performed to compare PCSM by primary treatment adjusting for age and case-mix.
RESULTS: 5,235 (54%) underwent RP, 1,138 (12%) BT, 1,307 (13%) EBRT, 1,262 (13%) PADT, and 832 (9%) AS/WW. During the 18-year follow-up period, 319 men (3%) died from prostate cancer. Median months to PCSM within 18 years were 70 (IQR 42-108). Adjusting for clinical CAPRA score the hazard ratios for PCSM relative to RP for BT, EBRT, PADT and AS/WW were 1.58 (95% CI, 1.04-2.40, p[0.03), 2.08 (95% CI, 1.54-2.82, p<0.01), 3.01 (95% CI, 2.22-4.10, p<0.01), and 2.07 (95% CI, 1.33-3.21, p<0.01), respectively. Two additional analyses using 100-Kattan score and a de novo model demonstrated similar results. In low-risk patients, no treatment modality showed a significant prostate-cancer specific survival benefit.
CONCLUSIONS: In a large, prospective, multi-center cohort of men with PCa, after rigorous case-mix adjustment, risk of PCa mortality was lowest with RP. Mortality was substantially higher with EBRT and AS/WW, and highest with PADT. The greatest difference was observed for high-risk patients. Therefore, we advise an increased role for RP in high-risk disease, and for AS/WW in lowrisk disease.
